Yan Ye1, Yan Mei Ge1, Miao Miao Xiao1, Li Mei Guo1, Qun Li1, Ji Qing Hao2, Jie Da2, Wang Lai Hu1, Xu Dong Zhang3, Jiegou Xu4, Lin Jie Zhang5. 1. Department of Immunology, Anhui Medical University, Hefei, 230032, Anhui, China. 2. Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. 3. School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia. 4. Department of Immunology, Anhui Medical University, Hefei, 230032, Anhui, China. xujiegou@ahmu.edu.cn. 5. Department of Immunology, Anhui Medical University, Hefei, 230032, Anhui, China. zlj33@ahmu.edu.cn.
Abstract
BACKGROUND: The Src homology 2-containing inositol 5-phosphatase 2 (SHIP2) is implicated in diabetes, arthrosclerosis, and cancer. However, the role of SHIP2 in human gastric cancer remains unclear. METHODS: The expression levels of SHIP2 in gastric cancer tissues, a panel of gastric cancer cell lines, and normal gastric epithelial cells were analyzed by immunohistochemistry (IHC), Western blot, and real-time quantitative RT-PCR (qRT-PCR). Gastric cancer cells with either overexpressed SHIP2 or co-overexpressed SHIP2 and Akt were analyzed to determine cell proliferation, colony formation, apoptosis, cell migration, and invasion assays. Normal gastric epithelial cells with knockdown SHIP2 or co-knockdown SHIP2 and Akt were subjected by anchorage-independent growth assays. The effect of SHIP2 on tumor growth in vivo was detected by xenograft tumorigenesis assays. RESULTS: SHIP2 was commonly downregulated in gastric cancer compared with normal gastric mucosa, and overexpression of SHIP2 inhibited cell proliferation, induced apoptosis, suppressed cell motility and invasion in gastric cancer cells in vitro, and retarded the growth of xenograft gastric tumors in vivo, while knockdown of SHIP2 in normal gastric epithelial cells promoted anchorage-independent growth. Moreover, overexpression of SHIP2 inactivated Akt, and upregulated p21, p27, and the pro-apoptotic protein Bim. Restoring Akt activation in gastric cancer cells largely blocked the inhibition of PI3K/Akt signaling by SHIP2 and reversed the inhibitory effect of SHIP2 on tumorigenesis and proliferation. CONCLUSIONS: This study demonstrates, for the first time, that SHIP2 is frequently downregulated in gastric cancer, and reduced SHIP2 expression promotes tumorigenesis and proliferation of gastric cancer via activation of the PI3K/Akt signaling.
BACKGROUND: The Src homology 2-containing inositol 5-phosphatase 2 (SHIP2) is implicated in diabetes, arthrosclerosis, and cancer. However, the role of SHIP2 in humangastric cancer remains unclear. METHODS: The expression levels of SHIP2 in gastric cancer tissues, a panel of gastric cancer cell lines, and normal gastric epithelial cells were analyzed by immunohistochemistry (IHC), Western blot, and real-time quantitative RT-PCR (qRT-PCR). Gastric cancer cells with either overexpressed SHIP2 or co-overexpressed SHIP2 and Akt were analyzed to determine cell proliferation, colony formation, apoptosis, cell migration, and invasion assays. Normal gastric epithelial cells with knockdown SHIP2 or co-knockdown SHIP2 and Akt were subjected by anchorage-independent growth assays. The effect of SHIP2 on tumor growth in vivo was detected by xenograft tumorigenesis assays. RESULTS:SHIP2 was commonly downregulated in gastric cancer compared with normal gastric mucosa, and overexpression of SHIP2 inhibited cell proliferation, induced apoptosis, suppressed cell motility and invasion in gastric cancer cells in vitro, and retarded the growth of xenograft gastric tumors in vivo, while knockdown of SHIP2 in normal gastric epithelial cells promoted anchorage-independent growth. Moreover, overexpression of SHIP2 inactivated Akt, and upregulated p21, p27, and the pro-apoptotic protein Bim. Restoring Akt activation in gastric cancer cells largely blocked the inhibition of PI3K/Akt signaling by SHIP2 and reversed the inhibitory effect of SHIP2 on tumorigenesis and proliferation. CONCLUSIONS: This study demonstrates, for the first time, that SHIP2 is frequently downregulated in gastric cancer, and reduced SHIP2 expression promotes tumorigenesis and proliferation of gastric cancer via activation of the PI3K/Akt signaling.
Authors: Christopher J Ong; Andrew Ming-Lum; Matt Nodwell; Ali Ghanipour; Lu Yang; David E Williams; Joseph Kim; Loutfig Demirjian; Pooran Qasimi; Jens Ruschmann; Li-Ping Cao; Kewei Ma; Stephen W Chung; Vincent Duronio; Raymond J Andersen; Gerald Krystal; Alice L-F Mui Journal: Blood Date: 2007-05-14 Impact factor: 22.113
Authors: Michael P Scheid; Michael Huber; Jacqueline E Damen; Michael Hughes; Veronica Kang; Paul Neilsen; Glenn D Prestwich; Gerald Krystal; Vincent Duronio Journal: J Biol Chem Date: 2002-01-07 Impact factor: 5.157
Authors: Zi Wang; Yao Nie; Kunxiao Zhang; Henghao Xu; Theresa A Ramelot; Michael A Kennedy; Maili Liu; Jiang Zhu; Yunhuang Yang Journal: Arch Biochem Biophys Date: 2018-08-27 Impact factor: 4.013
Authors: Yan Ye; Xue Yi Qian; Miao Miao Xiao; Yu Ling Shao; Li Mei Guo; Dong Ping Liao; Jie Da; Lin Jie Zhang; Jiegou Xu Journal: Int J Mol Sci Date: 2017-01-22 Impact factor: 5.923